RECRUITING

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study team will use small pieces of human hearts which are removed as part of a required surgical procedure to study different objectives. One of the objective is how calcium ions pass through the membrane of heart cells in order to tell the heart cell how much force to contract with when the heart beats. Investigators will also study the proteins and RNA of these pieces to determine how the newborn heart cells control their force of contraction differently from adult heart cells. Investigators hypothesize that infant hearts have different regulation of calcium entry than adult hearts. The study team also wants to study combinations of 3D cardiac spheres with multiple environmental cues that can improve functional and metabolic maturation of Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and generate a more clinically relevant cell model.

Official Title

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Quick Facts

Study Start:2005-04
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00243776

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 20 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients undergoing cardiopulmonary bypass surgery
  2. * Patients undergoing surgery for repair of congenital heart disease such as ventricular septal defect or defective mitral or aortic valves.
  1. * Prior cardiac surgery
  2. * History of atrial fibrillation or other atrial arrhythmias prior to operation
  3. * History of heart failure

Contacts and Locations

Study Contact

Michael E Davis, PhD
CONTACT
404-727-9858
medavis@emory.edu
Kati Miller
CONTACT
404-729-0492
kati.miller@choa.org

Principal Investigator

Michael E Davis, PhD
PRINCIPAL_INVESTIGATOR
Emory University

Study Locations (Sites)

Emory University School of Medicine
Atlanta, Georgia, 30322
United States

Collaborators and Investigators

Sponsor: Emory University

  • Michael E Davis, PhD, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2005-04
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2005-04
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Congenital Heart Disease
  • Tetralogy of Fallot